Some of these potential proteins (COL12A1, THBS2, S100A8, and S100A9) were reported to associate with other cancers and non-malignant diseases42,65–67, which limited the clinical validity of the potential proteins in CRC. This evidence concerns the gene THBS2 and colorectal carcinoma.